Expression of cytochrome P4502E1 gene in hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 10, Issue 11, 2004, Pages 1565-1568

  Man, Xiao Bo ^a   Tang, Liang ^a   Qiu, Xiu Hua ^a   Yang, Li Qun ^b   Cao, Hui Fang ^a   Wu, Meng Chao ^b   Wang, Hong Yang ^a  

^a SEMICONDUCTOR MANUFACTURING INTERNATIONAL CORPORATION   (China)

^b EASTERN HEPATOBILIARY SURGERY HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOCHROME P450 2E1; DIETHYLNITROSAMINE; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA MICROARRAY; DNA PROBE; ENZYME ANALYSIS; GENE EXPRESSION; LIVER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; NONHUMAN; NORTHERN BLOTTING; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION;

EID: 2942715301     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i11.1565     Document Type: Article

References (28)

1. Qin LX, Tang ZY. The prognostic significance of clinical and pathological features in hepatocellular carcinoma. World J Gastroenterol 2002; 8: 193-199
2. Ince N, Wands JR. The increasing incidence of hepatocellular carcinoma. N Engl J Med 1999; 340: 798-799
3. Llovet JM, Beaugrand M. Hepatocellular carcinoma: present status and future prospects. J Hepatol 2003; 38(Suppl 1): S136-S149
4. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002; 31: 339-346
5. Tannapfel A, Wittekind C. Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis. Virchows Arch 2002; 440: 345-352
6. Berns A. Gene expression in diagnosis. Nature 2000; 403: 491-492
7. Young RA. Biomedical discovery with DNA arrays. Cell 2000; 102: 9-15
8. Chen X, Cheung ST, So S, Fan ST, Barry C, Higgins J, Lai KM, Ji J, Dudoit S, Ng IO, Van De Rijn M, Botstein D, Brown PO. Gene expression patterns in human liver cancers. Mol Biol Cell 2002; 13: 1929-1939
9. Delpuech O, Trabut JB, Carnot F, Feuillard J, Brechot C, Kremsdorf DR. Identification, using cDNA macroarray analysis, of distinct gene expression profiles associated with pathological and virological features of hepatocellular carcinoma. Oncogene 2002; 21: 2926-2937
10. Lee JS, Thorgeirsson SS. Functional and genomic implications of global gene expression profiles in cell lines from human hepatocellular cancer. Hepatology 2002; 35: 1134-1143
11. Peterson JA, Graham SE. A close family resemblance: the importance of structure in understanding cytochromes P450. Structure 1998; 6: 1079-1085
12. Tanaka E, Terada M, Misawa S. Cytochrome P450 2E1: its clinical and toxicological role. J Clin Pharm Ther 2000; 25: 165-175
13. Southern E, Mir K, Shchepinov M. Molecular interactions on microarrays. Nat Genet 1999; 21(Suppl): 5-9
14. Schlaak JF, Hilkens CM, Costa-Pereira AP, Strobl B, Aberger F, Frischauf AM, Kerr IM. Cell-type and donor-specific transcriptional responses to interferon-alpha. Use of customized gene arrays. J Biol Chem 2002; 277: 49428-49437
15. Mochii M, Yoshida S, Morita K, Kohara Y, Ueno N. Identification of transforming growth factor-beta- regulated genes in caenorhabditis elegans by differential hybridization of arrayed cDNAs. Proc Natl Acad Sci U S A 1999; 96: 15020-15025
16. Cheung VG, Morley M, Aguilar F, Massimi A, Kucherlapati R, Childs G. Making and reading microarrays. Nat Genet 1999; 21 (1 Suppl): 15-19
17. Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus IC, Nebert DW. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996; 6: 1-42
18. Umeno M, McBride OW, Yang CS, Gelboin HV, Gonzalez FJ. Human ethanol-inducible P450IIE1: complete gene sequence, promoter characterization, chromosome mapping, and cDNA-directed expression. Biochemistry 1988; 27: 9006-9013
19. Umeno M, Song BJ, Kozak C, Gelboin HV, Gonzalez FJ. The rat P450IIE1 gene: complete intron and exon sequence, chromosome mapping, and correlation of developmental expression with specific 5′ cytosine demethylation. J Biol Chem 1988; 263: 4956-4962
20. Tsutsumi M, Takada A, Wang JS. Genetic polymorphisms of cytochrome P4502E1 related to the development of alcoholic liver disease. Gastroenterology 1994; 107: 1430-1435
21. Ueshima Y, Tsutsumi M, Takase S, Matsuda Y, Kawahara H. Acetaminophen metabolism in patients with different cytochrome P-4502E1 genotypes. Alcohol Clin Exp Res 1996; 20(1 Suppl): 25A-28A
22. Wong NA, Rae F, Simpson KJ, Murray GD, Harrison DJ. Genetic polymorphisms of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: a study and literature review, including meta-analysis. Mol Pathol 2000; 53: 88-93
23. Chen CJ, Yu MW, Liaw YF. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 1997; 12: S294-308
24. Yu MW, Gladek-Yarborough A, Chiamprasert S, Santella RM, Liaw YF, Chen CJ. Cytochrome p4302E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology 1995; 109: 1266-1273
25. Ladero JM, Agundez JA, Rodriguez-Lescure A, Diaz-Rubio M, Benitez J. Rsal polymorphism at the cytochrome P4502E1 locus and risk of hepatocellular carcinoma. Gut 1996; 39: 330-333
26. Rumack BH. Acetaminophen hepatotoxicity: the first 35 years. J Toxicol Clin Toxicol 2002; 40: 3-20
27. Johansson I, Eliasson E, Norsten C, Ingelman-Sundberg M. Hydroxylation of acetone by ethanol-and acetone-inducible cytochrome P-450 in liver microsomes and reconstituted membranes. FEBS Lett 1986; 196: 59-64
28. Nakajima T, Elovaara E, Park SS, Gelboin HV, Hietanen E, Vainio H. Immunochemical characterization of cytochrome P-450 isozymes responsible for benzene oxidation in the rat liver. Carcinogenesis 1989; 10: 1713-1717